转债代码：123251 转债简称：华医转债 证券代码：301235 证券简称：华康洁净 公告编号：2025-112 武汉华康世纪洁净科技股份有限公司 关于收到中标通知书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 武汉华康世纪洁净科技股份有限公司（以下简称"公司"）于 2025 年 8 月 28 日在创业板信息披露网站巨潮资讯网（www.cninfo.com.cn）上披露了《关于 项目预中标的提示性公告》（公告编号：2025-104）。近日，公司收到招标人浙 江滨海新区投资发展集团有限公司发出的《中标通知书》，确认公司为"浙江省 肿瘤医院绍兴院区(浙江滨海医院)新建工程医用净化专项工程"项目的中标供应 商。现将中标项目的主要内容公告如下： 7、工程质量：合格，配合总承包单位确保钱江杯，争创鲁班奖。 二、交易对手方情况 1、单位名称：浙江滨海新区投资发展集团有限公司 2、法定代表人：赵溢峰 一、中标项目基本情况 1、建设地点：绍兴滨海新区江滨区,海滨路以西,开元东路以南,海华路以东, 乾诚道以北。 2、 建设规模：本项目为综合三甲医院，总建筑面积约 5 ...

Core Viewpoints - The report highlights the strong growth potential of Huakang Clean (301235) in the cleanroom integration service sector, driven by its dual focus on medical and electronic markets [4][10][12] - The company has a robust order backlog, with medical and laboratory cleanroom orders increasing from 1.727 billion yuan in 2022 to 3.706 billion yuan in the first half of 2025, indicating sustained revenue growth [4][10][12] - The establishment of an electronic division in 2024 is expected to enhance the company's market presence in the electronic cleanroom sector, leveraging existing expertise and local resources [4][10][12] - The report projects significant revenue growth for the company, with expected revenues of 2.542 billion yuan, 3.547 billion yuan, and 4.598 billion yuan for 2025-2027, representing year-on-year growth rates of 49%, 40%, and 30% respectively [4][10][12] Summary by Sections Company Overview - Huakang Clean was established in 2008 and has 17 years of experience in the cleanroom integration service industry, recognized as a national high-tech enterprise [4][10][12] - The company offers a full industry chain capability, including design, construction, procurement, and after-sales service, covering medical, laboratory, and electronic cleanroom sectors across over 20 provinces and regions in China [4][10][12] Medical Business Growth - The medical cleanroom market is fragmented, and Huakang Clean has successfully expanded its business despite challenging macroeconomic conditions [4][10][12] - The company has accumulated technical experience in hospital projects, which has facilitated its entry into the laboratory cleanroom sector [4][10][12] Electronic Cleanroom Sector - The company plans to leverage its medical sector experience to enter the larger electronic cleanroom market, having already secured multiple projects with high-profile clients [4][10][12] - The strategy involves targeting high-tier clients and their supply chains to ensure a successful market entry [4][10][12] Financial Projections - The report forecasts net profits of 153 million yuan, 225 million yuan, and 332 million yuan for 2025-2027, with growth rates of 129%, 47%, and 47% respectively [4][10][12] - The estimated reasonable market value for the company is 5.1 billion yuan, indicating a potential upside of approximately 43% from its market value as of September 15, 2025 [4][10][12]

Core Insights - The report highlights the strong growth potential of Huakang Clean (301235) in the cleanroom integration service sector, focusing on both medical and electronic fields [2][3][5] - The company has a robust order backlog, with orders in hand for medical and laboratory cleanrooms increasing from 1.727 billion to 3.706 billion from 2022 to the first half of 2025, indicating sustained revenue growth [3][12] - The establishment of an electronic division in 2024 aims to leverage existing expertise and local resources, targeting a larger market in electronic cleanrooms [3][12] - The report projects significant revenue growth for Huakang Clean, estimating revenues of 2.542 billion, 3.547 billion, and 4.598 billion for 2025-2027, with corresponding net profits of 153 million, 225 million, and 332 million [3][12] Company Overview - Huakang Clean has been operating in the cleanroom integration service industry for 17 years, providing a full range of services including design, construction, procurement, and after-sales support [3][12] - The company serves over 800 high-quality clients across various sectors, including major hospitals and electronics firms [3][12] Market Dynamics - The medical cleanroom market is characterized by fragmentation, but Huakang Clean has successfully expanded its business despite challenging macroeconomic conditions [3][12] - The electronic cleanroom market is expected to grow, with Huakang Clean's strategy of targeting high-tier clients and their supply chains showing early success [3][12] Financial Projections - The report anticipates a compound annual growth rate (CAGR) of 49%, 40%, and 30% for revenues from 2025 to 2027, alongside a significant increase in net profit margins [3][12] - The estimated market valuation for Huakang Clean is projected at 5.1 billion, suggesting a potential upside of approximately 43% from its market value as of September 15, 2025 [3][12]

Market Overview - The Shanghai Composite Index closed at 3821.83 points, with a decline of 0.18% [1] - The total trading volume of A-shares reached 25,184.71 billion yuan [1] Technical Analysis - A total of 171 A-shares experienced a death cross, where the 5-day moving average fell below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Innovation Medical: 5-day MA at 22.60 yuan, 10-day MA at 23.25 yuan, a difference of -2.80% [1] - Xiangyu Medical: 5-day MA at 54.48 yuan, 10-day MA at 55.33 yuan, a difference of -1.54% [1] - Northern Long Dragon: 5-day MA at 122.21 yuan, 10-day MA at 123.92 yuan, a difference of -1.38% [1] Stock Performance - Key stocks with notable declines include: - Innovation Medical: down 2.97% with a turnover rate of 16.99% [1] - Xiangyu Medical: down 5.95% with a turnover rate of 2.14% [1] - Northern Long Dragon: down 2.23% with a turnover rate of 20.67% [1] - Other stocks with significant declines include: - Aorui: down 5.25% [1] - Changbai Mountain: down 7.15% [1] - Hengbao Shares: down 6.73% [1]

Market Overview - The Shanghai Composite Index closed at 3781.61 points, with a decline of 1.23% [1] - The total trading volume of A-shares reached 1713.539 billion yuan [1] Technical Analysis - A total of 228 A-shares experienced a death cross, where the 5-day moving average fell below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Innovation Medical: 5-day MA at 22.55 yuan, 10-day MA at 23.23 yuan, a difference of -2.92% [1] - North Long Dragon: 5-day MA at 121.67 yuan, 10-day MA at 123.65 yuan, a difference of -1.60% [1] - Xiangyu Medical: 5-day MA at 54.49 yuan, 10-day MA at 55.34 yuan, a difference of -1.53% [1] Individual Stock Performance - Significant declines in stock prices include: - Innovation Medical: down 4.27% with a turnover rate of 14.36% [1] - North Long Dragon: down 4.52% with a turnover rate of 13.85% [1] - Xiangyu Medical: down 5.86% with a turnover rate of 1.42% [1] - Other notable declines: - Shandong Mining Machine: down 4.43% [1] - Huakang Clean: down 6.50% [1] - Beautiful Ecology: down 5.15% [1] Additional Stock Data - The following stocks also showed significant declines: - Yuyin Co.: down 5.46% [2] - Kexin Information: down 5.22% [1] - Visual China: down 3.88% [1] - Stocks with notable trading activity include: - Hengbao: down 6.64% with a turnover rate of 10.88% [2] - Changbai Mountain: down 6.53% with a turnover rate of 4.05% [2]

证券日报网讯 9月22日晚间，华康洁净发布公告称，公司实际控制人、控股股东谭平涛先生、胡小艳女 士在云南国际信托有限公司办理了股票解除质押业务。本次解除质押股份共计15，000，000股，占公司 总股本比例13.92%。 （文章来源：证券日报） ...

证券代码：301235 证券简称：华康洁净 公告编号：2025-111 转债代码：123251 转债简称：华医转债 武汉华康世纪洁净科技股份有限公司 关于公司实际控制人、控股股东股份解除质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 武汉华康世纪洁净科技股份有限公司（以下简称"公司"）近日接到公司实 际控制人、控股股东谭平涛先生、胡小艳女士的通知，获悉其所持有的公司股份 办理了解除质押业务，具体事项如下： 注 1：因公司可转债进入转股期，截至 2025 年 9 月 19 日，公司总股本为 107,767,268 股，本公告中计算占公司总股本比例以此为基数计算。 注 2：计算持股比例时，公司总股本未剔除回购专用账户中的股份数，下同。 二、股东股份累计质押情况 截至公告披露日，上述股东及其一致行动人所持质押股份情况如下： | | | | | 本次解 | | | 已质押股份情况 | | 未质押股份情况 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | ...

Core Viewpoint - The stock of Huakang Clean has experienced fluctuations, with a year-to-date increase of 60.86% but a recent decline in the last five and twenty trading days [1][2]. Company Overview - Huakang Clean is based in Wuhan, Hubei Province, and was established on November 12, 2008, with its listing date on January 28, 2022. The company specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1]. - The revenue composition of Huakang Clean includes: 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation services, and 0.61% from other sources [1]. Financial Performance - For the first half of 2025, Huakang Clean achieved an operating income of 835 million yuan, representing a year-on-year growth of 50.73%. The net profit attributable to the parent company was 18.68 million yuan, showing a significant increase of 273.48% [2]. - Since its A-share listing, Huakang Clean has distributed a total of 40.02 million yuan in dividends, with 29.46 million yuan distributed over the past three years [3]. Shareholder Information - As of September 10, 2023, Huakang Clean had 10,300 shareholders, a decrease of 8.37% from the previous period. The average number of circulating shares per person increased by 9.14% to 7,056 shares [2]. - Notable institutional holdings include Anxin Medical Health Stock A as the fifth largest shareholder with 652,800 shares, and Nuoan Multi-Strategy Mixed A as the tenth largest shareholder with 429,900 shares, both being new shareholders [3].

Group 1 - The company has been deeply engaged in the cleanroom integration service sector for 17 years, established in 2008, and is recognized as a national high-tech enterprise with a full industry chain capability covering design, construction, procurement, and after-sales service [1] - The company has a strong growth in the medical cleanroom market, with a backlog of orders increasing from 1.727 billion yuan in 2022 to 3.706 billion yuan in the first half of 2025, ensuring sustained growth in its medical business [1] - The company has successfully entered the electronic cleanroom sector by leveraging its experience in the medical field, establishing an electronic division in 2024, and winning multiple projects from high-level clients [2] Group 2 - The company is expected to achieve revenues of 2.542 billion yuan, 3.547 billion yuan, and 4.598 billion yuan for the years 2025 to 2027, representing year-on-year growth rates of 49%, 40%, and 30% respectively [2] - The projected net profit attributable to the parent company for the same period is expected to be 153 million yuan, 225 million yuan, and 332 million yuan, with year-on-year growth rates of 129%, 47%, and 47% respectively [2] - The company's reasonable market value is estimated at 5.1 billion yuan, indicating a potential upside of approximately 43% relative to its market value as of September 15, 2025, leading to a "buy" rating [2]

Investment Rating - The report initiates coverage with a "Buy" rating for Huakang Clean Technology Co., Ltd. [1][7] Core Views - The company has a strong order backlog and a robust capability to win medical contracts, ensuring long-term stable growth in its medical business. The successful entry into the electronic cleanroom sector provides high growth potential. Revenue projections for 2025-2027 are CNY 25.42 billion, CNY 35.47 billion, and CNY 45.98 billion, with year-on-year growth rates of 49%, 40%, and 30% respectively. Net profit forecasts are CNY 1.53 billion, CNY 2.25 billion, and CNY 3.32 billion, with growth rates of 129%, 47%, and 47% respectively. The company's reasonable market capitalization is estimated at CNY 5.1 billion, indicating a potential upside of approximately 43% from its market value as of September 15, 2025 [6][7]. Summary by Sections 1. Deepening Cleanroom Field, Continuous High Growth - Huakang Clean has been deeply engaged in the cleanroom integration service sector for 17 years, providing comprehensive services including design, construction, procurement, and after-sales support. The company has served over 800 high-quality clients across various sectors, including healthcare and electronics [6][20][21]. - The company has achieved continuous revenue growth since 2017, with a CAGR of 24%. In the first half of 2025, revenue reached CNY 835 million, a year-on-year increase of 51% [23][26]. 2. Long-term Stable Medical Demand, High Prosperity in Electronics - The cleanroom market is expected to exceed CNY 500 billion by 2032, with a projected CAGR of over 7% from 2023 to 2032. The medical cleanroom market is driven by the increasing number of hospitals and the rising demand for ICU and surgical facilities [42][66]. - The electronic cleanroom market is also anticipated to grow significantly, supported by the high capital expenditure in the semiconductor industry, which is projected to remain robust [71][80]. 3. Increased Market Share in Medical Sector, Strong Entry into Electronics - The company has successfully expanded its market share in the medical cleanroom sector despite a challenging macro environment. The order backlog for medical and laboratory cleanrooms has grown from CNY 1.727 billion in 2022 to CNY 3.706 billion in the first half of 2025 [6][9]. - The establishment of the electronic cleanroom division in 2024 has allowed the company to tap into a larger market, leveraging its technical expertise and local resources [6][9]. 4. Profit Forecast and Valuation - The company is expected to maintain high growth, with revenue projections of CNY 25.42 billion, CNY 35.47 billion, and CNY 45.98 billion for 2025-2027. The net profit is forecasted to be CNY 1.53 billion, CNY 2.25 billion, and CNY 3.32 billion for the same period [5][7].